CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $40,883
- in 1 filing
Net +$959,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-09 | Koppikar Utpal Chief Financial Officer | Sale | −3,924 | $10.18 | $40K | 135,026 |
| 2020-05-18 | Newell Joe Chief Operations Officer | Sale | −1,603 | $11.22 | $18K | 123,881 |
| 2020-05-18 | Koppikar Utpal Chief Financial Officer | Sale | −1,428 | $11.22 | $16K | 137,375 |
| 2020-05-18 | Touchon Pascal President and CEO | Sale | −3,195 | $11.22 | $36K | 276,979 |
| 2020-05-14 | Dupont Jakob EVP, Head of R&D | Grant or award | +46,250 | 46,250 | ||
| 2020-05-14 | Dupont Jakob EVP, Head of R&D | Grant or award · Employee Stock Option (Right to Buy) | +277,500 | 277,500 | ||
| 2020-05-11 | Roncarolo Maria Grazia Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +59,500 | 59,500 | ||
| 2020-04-29 | Renaud Ronald C JR Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +71,500 | 71,500 | ||
| 2020-04-20 | Murugan Amar SVP, GC & Secretary | Grant or award | +55,000 | 55,000 | ||
| 2020-04-20 | Murugan Amar SVP, GC & Secretary | Grant or award · Employee Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2020-04-06 | Newell Joe Chief Operations Officer | Sale | −657 | $7.94 | $5K | 125,484 |
| 2020-03-27 | Koppikar Utpal Chief Financial Officer | Sale | −1,827 | $9.17 | $17K | 137,330 |
| 2020-03-27 | Newell Joe Chief Operations Officer | Sale | −2,740 | $9.17 | $25K | 126,141 |
| 2020-03-01 | Koppikar Utpal Chief Financial Officer | Grant or award | +66,875 | 139,157 | ||
| 2020-03-01 | Koppikar Utpal Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +73,750 | 73,750 | ||
| 2020-03-01 | Yarema Kristin Chief Commercial Officer | Grant or award | +55,000 | 55,000 | ||
| 2020-03-01 | Newell Joe Chief Operations Officer | Grant or award | +75,000 | 128,881 | ||
| 2020-03-01 | Newell Joe Chief Operations Officer | Grant or award · Employee Stock Option (Right to Buy) | +53,000 | 53,000 | ||
| 2020-03-01 | Newell Joe Chief Operations Officer | Grant or award · Employee Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2020-03-01 | Touchon Pascal President and CEO | Grant or award | +150,000 | 280,174 |
Page 18 of 29 · 569 trades